Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Jin-Seok Ahn"'
Autor:
Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park, Jeong Eon Lee, Eunjoo Jeon, Ji-Yeon Kim, Eun Yoon Cho, Se Kyung Lee, Sunghoon Joo, Youngmin Park, Seok Jin Nam, Hyungsik Jung, Soonhwan Kwon
Publikováno v:
Breast Cancer Research and Treatment. 189:747-757
BackgroundThe aim of this study was to develop a machine learning(ML) based model to accurately predict pathologic complete response(pCR) to neoadjuvant chemotherapy(NAC) using pretreatment clinical and pathological characteristics of electronic medi
Autor:
Jeeyun Lee, Jong Mu Sun, Seokuee Kim, Jin Seok Ahn, Jung-Ryul Kim, Sujong Kim, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park, Rae O. Han, Myung-Ju Ahn
Publikováno v:
Expert Opinion on Investigational Drugs. 29:1059-1067
We evaluated the tolerability, pharmacokinetics (PK) and preliminary efficacy of KML001, an oral trivalent arsenical, as a monotherapy in patients with advanced solid tumors.With a standard 3 + 3 design for dose-escalation stage, the planned dose lev
Autor:
Hyun Ae Jung, Se-Hoon Lee, Myung-Ju Ahn, Keunchil Park, Ji Yun Lee, Jin Seok Ahn, Jong-Mu Sun, Sehhoon Park
Publikováno v:
Expert Opinion on Pharmacotherapy. 21:1935-1942
Entrectinib, an oral pan-TRK, ALK, and ROS1 inhibitor is approved as a first-line treatment for NTRK-rearranged solid tumors and ROS1-rearranged non-small cell lung cancer (NSCLC). It has demonstrated clinical efficacy for patients harboring the rele
Autor:
Hyun Ae Jung, Yunjoo Im, Keunchil Park, Jong-Mu Sun, Se-Hoon Lee, Sun Hye Shin, Jin Seok Ahn, Myung-Ju Ahn, Hye Yun Park, Ho Yun Lee
Publikováno v:
International Journal of Cancer. 145:2433-2439
Emerging immune profiling data suggest a higher sensitivity to immune checkpoint inhibitors (ICIs) in nonsmall cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD), compared to those without COPD. This study aimed to in
Autor:
Hyeokgon Park, Danbee Kang, Juhee Cho, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park, Ji-Yeon Kim, Eunjoo Kim, Di Zhao, Nayeon Kim, Eliseo Guallar
Publikováno v:
Journal of the American Academy of Dermatology. 87(4)
Autor:
Moon Young Choi, Eun Kyung Cho, Hoon Gu Kim, Jinhyun Cho, Hye Ryun Kim, Ha Yeon Lee, Heui June Ahn, Keunchil Park, Ki Hyeong Lee, Myung-Ju Ahn, Hwan Jung Yun, Jin Hyoung Kang, Se-Hoon Lee, Su Jin Lee, K.H. Yoo, Yoonhee Choi, Sin-Ho Jung, Jong Mu Sun, Keon Uk Park, Jin Seok Ahn, Jaeheon Jeong, Kihwan Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The optimal cytotoxic regimens have not been established for patients with non-small cell lung cancer (NSCLC) who develop disease progression on first-line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Materials and m
Autor:
Keunchil Park, Hyebin Lee, Kyung Hwa Lee, Hongryull Pyo, Jin Seok Ahn, Eonju Lee, Tae Gyu Kim, Heerim Nam, Myung-Ju Ahn, Seung Gyu Park, Jong-Mu Sun, Yong Chan Ahn, Jae Myoung Noh
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study is to report clinical outcomes of salvage concurrent chemo-radiation therapy (CCRT) in treating patients with loco-regional recurrence (LRR) following initial complete resection of non-small cell lung cancer. Materials and Methods
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We tried to evaluate whether there are any specific features in treatment outcomes of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), compared with gefitinib or erlotinib.
Autor:
Jin Seok Ahn, Keunchil Park, Se-Hoon Lee, Hyun Ae Jung, Jong-Mu Sun, Jang Ho Cho, Myung-Ju Ahn
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 145:1341-1349
We evaluated the predictive role of EGFR mutation on the efficacy of PD-1/PD-L1 inhibitor therapy in patients with advanced pulmonary adenocarcinoma while considering clinical factors such as PD-L1 expression, gender, and smoking status. Patients wer
Autor:
Jong Han Yu, Soo-Hyeon Lee, Sung Won Lim, Jang Ho Cho, Song Ee Park, Jin Seok Ahn, Yu Jin Kim, Young-Hyuck Im, Hee Kyung Kim, Ji-Yeon Kim, Hansang Lee, Yeon Hee Park
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer
BMC Cancer
Background In this study, we observe the patterns initial palliative treatment for premenopausal patients with HR-positive/HER2-negative MBC and determine if nonadherence to clinical guidelines are associated with worse clinical outcomes in terms of